Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 10/07/2026 |
| תאריכים נוספים | 10/11/2026 |
| פקולטה | Engineering, Exact Sciences, Life Sciences, Medicine |
| תיאור | The National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research.
Funding: $150,000 per year Duration: 3 years
Research Authority due date: 10 days prior to submission. |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 14/06/2026 |
